Sort
130,381 grants matching “hiv”
NIAID VIROLOGY QUALITY ASSURANCE
$2,956,406James Bremer · Rush University Medical Center · N01 · FY2014 · AI
China's Integrated Programs for Research on AIDS
$2,955,968National Center/Aids/Std Control/Prevent · U19 · FY2004 · AI
HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027
$2,955,783Linda-Gail Bekker · University Of Cape Town · UM1 · FY2021 · AI
Vaccination against mucosal HIV clade C transmission
$2,955,315Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · P01 · FY2009 · AI
Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit
$2,954,579Scott M Hammer · Columbia University Health Sciences · UM1 · FY2014 · AI
UAB-MISS MACS/WIHS Combined Cohort Study
$2,954,063Mirjam-Colette Kempf · University Of Alabama At Birmingham · U01 · FY2022 · HL
Women's Interagency HIV Study (WIHS) III
$2,953,140Suny Downstate Medical Center · U01 · FY2004 · AI
Center for AIDS Research
$2,952,749James A Hoxie · University Of Pennsylvania · P30 · FY2014 · AI
UCSF-GVI Center for AIDS Research
$2,952,540Paul A Volberding · University Of California, San Francisco · P30 · FY2016 · AI
Clinical Trials Units for NIAID Networks (UM1)
$2,952,539Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2014 · AI
Engineering T cells to Provide Durable Control of HIV-1 Replication
$2,951,367James L Riley · University Of Pennsylvania · U19 · FY2017 · AI
HPV Vaccine Trial
$2,949,855Allan Hildesheim · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
INSPIRE: Innovative Strategies for Personalized Immunotherapies and Reservoir Eradication
$2,948,452R. Brad Jones · Weill Medical Coll Of Cornell Univ · UM1 · FY2025 · AI
Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site
$2,948,385Cecile Delille Lahiri · Emory University · U01 · FY2025 · HL
Strategies for Eliciting bnAbs against Conserved HIV-1 Quaternary Epitopes
$2,947,908Abraham Pinter · Rbhs-New Jersey Medical School · P01 · FY2014 · AI
Optimization of HIV vaccines for the induction of cross-reactive antibodies
$2,947,202Shan Lu · Univ Of Massachusetts Med Sch Worcester · U19 · FY2013 · AI
Center for AIDS Research
$2,946,696Ronald G Collman · University Of Pennsylvania · P30 · FY2017 · AI
Targeted Long-acting Combination Antiretroviral Therapy (TLC-ART)
$2,946,499Rodney J.y. Ho · University Of Washington · UM1 · FY2018 · AI
University of Pennsylvania HIV Clinical Trials Unit
$2,946,326Ian Frank · University Of Pennsylvania · UM1 · FY2024 · AI
PHRU-Setshaba Clinical Trials Unit
$2,946,297Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2025 · AI
HIV TREATMENT FOR RESEARCH SUBJECTS OR BY RESEARCHERS IN KENYA
$2,945,000Lawrence Gelmon · University Of Manitoba · U62 · FY2009 · PS
Case AIDS Clinical Trials Unit
$2,944,131Michael Marcel Lederman · Case Western Reserve University · UM1 · FY2013 · AI
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$2,942,898Pablo Tebas · University Of Pennsylvania · UM1 · FY2019 · AI
Strategies for Eliciting bnAbs against Conserved HIV-1 Quaternary Epitopes
$2,942,662Abraham Pinter · Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2011 · AI
The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuum
$2,942,520Lisa B Hightow-Weidman · Univ Of North Carolina Chapel Hill · U19 · FY2017 · HD